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Abstract
Background: The development of Systemic Lupus 
Erythematosus (SLE) treatment has led the increased 
of patients survival. Quality of life has became a value 
based medicine component that should be evaluated in 
treating SLE. One standardized questionnaire to asses 
the quality of life in SLE patients is Lupus Quality of Life 
(Lupus QoL). Currently, in Indonesia, there has not been 
any spesific questionnaire to asses the quality of life in 
SLE patients. This study aims to prove that Lupus QoL 
is valid and reliable to asses the quality of life in SLE 
patients in Indonesia. 
Methods: This study used cross sectional study 
method. Firstly, we translated the Lupus QoL into 
Indonesian language, then we tested to 10 respondents. 
Then, we continued the study with larger sample size. 
We analyzed the reliability of the test and the re-test 
result using the interclass coefficient correlation and the 
internal consistency of the tests using cronbach alpha. 
Construct validity was evaluated using multi trait scaling 
analysis and the extrenal validity was evaluated using 
correlation between domains in short form 36 (SF 36) 
with Lupus QoL and with disease activity. 
Results: Data collection was done to 65 SLE patients 
between October – November 2015 in RSCM. The test 
has good external validity SF 36 (r=0.38-0.66, p<0.05) 
and good construct validity (r >0.4; range: 0.44-0.93). 
The ICC value in one week >0.7 and Cronbach α was 
>0.7 in each domain. The correlation between lupus 
QoL and the disease activity was weak and consistent 
with other studies. 
Conclusion: Lupus QoL questionnaire is valid and 
reliable to asses the quality of life in SLE patients in 
Indonesia.
Key words: Quality of Life, Systemic Lupus 
Erythematosus, Lupus QoL, Validity, Reliability
Introduction
Systemic Lupus Erythematosus (SLE) is 
an autoimmune disease that caused chronic 
inflammation with varied clinical manifestations 
and prognosis.1 SLE is classified by period of 
acute attack and remission.2 SLE patients have 
higher morbidity and mortality compared to 
general population.1,2 The development of SLE 
therapy has benefit in increasing the survival of 
SLE patients. This shift the fact that quality of 
life (QoL) in SLE patients is now substantial to 
be evaluated. However, there is a different goal 
perception between the clinicians and the patients. 
International consensus has written that QoL is a 
basic evaluation in patients with SLE that has to be 
assessed by clinicians beside the disease activity, 
organ damage, side effect of therapy and economic 
impact. 3-9 The QoL of SLE patients is lower than 
general population or others chronic illnesses. The 
disease activity and organ damage reated to SLE 
progression inconsistently impact the QoL in SLE 
patients.3,10-14 While, the disease or organ damage 
prior to SLE has a strong connection to reduce QoL 
in SLE. 15-16 
 SLE QoL can be evaluated by general or spesific 
questionnaire.17 The general questionaire that 
proven valid and reliable are Short Form 36 Health 
Survey ( SF 36 ) and Euro-QoL 5 - Dimensional 
(EQ 5D).17 However, since its used for general 
population, these questionaires do not cover spesific 
SLE impairment, such as sleep disturbances, sexual 
dysfunction, and body perception disturbances.18 
Nowdays, specific questionaires for assesing QoL 
in SLE patients, such as Lupus QoL, SLE QoL 
dan L – QoL. These three questionnaire have been 
proven valid and reliable to measure quality of 
life in SLE. Clinical review by Holloway et al has 
shown that Lupus QoL has a better validity in each 
evaluated domain compared to others.17,19-25 Lupus 
QoL has proven valid and reliable to evaluate the 
quality of life in SLE. Still there has no research to 
evaluate the validity and reliability of Lupus Qol in 
Indonesian language in SLE patients in Indonesia. 
This research is trying to prove the validity and 
reliability in Lupus Qol in Indonesian language 
to evaluate the quality of life in SLE patirnts in 
Indonesia. 
Methodology
Study design
This was a cross sectional study in the SLE patients 
that went to the internal medicine clinics in RSCM 
in October until November 2015.
Subject
Subjects were included using consecutive sampling 
method. SLE patients who visited RSCM Internal 
Medicine clinics in period October – November 
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2015 and willing to enter the study were included as subjects. 
Subjects were excluded if they have cognitive impairment, so 
that their quality of life can not be evaluated. 
 All subjects were evaluated by analyzing their history in 
medical records, taking comprehensive anamnesis, physical 
examination, and labortory examination. The collected data, 
include:
1. Subject characteristic :age, sex, body weight, last 
education, insurance, duration of SLE, diagnosis, disease 
activity by using MEX SLEDAI and drugs that were used.
2. Physical examination : arthritis and joint swelling that 
were evaluated by MEX SLEDAI.
3. Quality of life were evaluated using Lupus QoL and SF 36 
questionnaire. 
4. Reevaluation of Lupus QoL, one week after first encounter.
Lupus QoL Questionnaire Preparation
Lupus QoL quistionnaire were prepared within two phase. 
First, the original version of Lupus QoL questionnaire was 
translated to Indonesian language. We have got permission 
from the original author for the translating process. For 
translating purpose, we used 2 certified translator from 
Lembaga Bahasa Universitas Indonesia (LBUI). The 
translation then were evaluated and synthesized into 
Indonesian Lupus QoL questionnaire. The validity of the 
Indonesian Lupus QoL quistionnaire version then was tested 
to 10 subjects, the subjects are allowed to give input for the 
fixation. If the questionaire validity no difference with the 
orginal version, then we can continue to the second phase. 
The questionnaire should be fixed, if it is still not valid. The 
validity process could be done several times until we got 
the Indonesian version quiestionaire that have no difference 
validity with the orginal version.
 In the second phase, we assessed all the study subjects 
using the Indonesian version of Lupus QoL quistionnaire. For 
external validity, we used SF 36 quistionnaire as our control. 
Data analysis
All of the data were documented in study form. Data were 
validated and processed, using SPSS (Statistical Package 
for the Social Sciences) 20th version. Data were analyzed 
using Kolmogorov – Smirnov test, Pearson or Spearman test, 
Intra class Correlation Coefficient (ICC) and Cronbach α 
coefficient. 
 The validity of Lupus QoL questionnaire was evaluated 
by analysing external and construction validity. The external 
validity was analyzed by having correlation coefficient 
between SF 36 and Lupus QoL. The construction validity was 
analyzed by having the correlation coefficient in each question 
compared to total number.
 The Cronbach α value was considered good when > 0.7, 
the Spearman correlation coefficient considered strong when 
> 0.5.11  In this study  we used cut off value of r >0.7 was 
considered strong, 0.3 – 0.7 was moderate and > 0.3 were 
weak.24 
Results
Subject charasteristic
Sixty five patients SLE patients were enrolled to the study 
using the consecutive sampling method. The characteristics of 
the subject were shown in the table 1.
 
Table 1. Subject Epidemiological Characteristic
Characteristic Frequency ( % )
1. Sex
Male
Female
2. Age
18 – 25
26 – 30
31 – 35
36 – 40
41 – 60
3. Education
< Elementary School
Elementary School
Junior High School
Senior High School
University ( D1 – S3 )
4. Occupancy
Work
Housewives
Student
Not working
5. Marital Status
Married
Not married/ divorce
6. Duration of illness
< 5 years
5 – 10 years
11 – 15 years
More than 15 years
7. Organ Involvement
Mucocutaneus
Musculosceletal
Hematology
KIdney
Neuropsychiatric
8. Organ involvement combination
Mucocutaneus and musculosceletal
Mucocutaneus and hematology
Mucocutaneus, musculosceletal and kidney
Mucocutaneus, musculosceletal, hematology
Kidney, hematology, neuropsychiatry
Mucocutaneus, kidney, hematology
Mucocutaneus, musculoskeletal, kidney, hematology
Mucocutaneus, musculoskeletal, kidney, neuropsychiatry
9. Therapy
Steroid
Single Immunosupresant agent
Steroid + Chloroquine
Steroid  + Azatioprine
Steroid + Metothrexate
Steroid + Mofetil mycophenolate
Steroid + Cyclosporine
Imuran + Chloroquine
Steroid + Cyclophosphamide
More than 2 regimens
Without treatment
10. MEX SLEDAI
0 
1
2
3
4
6
9
2 (3.1)
63 ( 96.9)
1 (1.5)
4 ( 6.2)
11 (16.9)
35 ( 53.8 )
14 ( 21.54)
1 (1.5)
4 ( 6.2)
11 (16.9)
35 ( 53.8 )
14 ( 21.54)
22 ( 33.8 )
36 ( 55.4 )
4 ( 6.2 )
3( 4.6 )
46 (71)
19 (29)
31 ( 47.7 )
24 ( 36.9)
7 ( 10.8 )
3( 4.6 )
61
59
14
10
1
38 ( 58.5 )
2  ( 3.1 )
6 ( 9.2 )
9 ( 13.8 )
2 ( 3.1 )
2 ( 3.1 )
3 ( 4.6 )
1 ( 1.5 )
16 ( 24.6 )
10 ( 15.4 )
14 ( 11.5 )
18 ( 12.3 )
1 ( 1.5 )
3 ( 4.6 )
2 ( 3.1 )
1 ( 1.5 )
1 ( 1.5 )
7 ( 10.8 )
2 ( 3.1 )
48  ( 73.8 )
1  ( 1.5 )
8 ( 12.3 )
2  ( 3.1 )
1  ( 1.5 )
4  ( 6.2 )
1 ( 1.5 )
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Lupus QoL questionnaire translation
In the validity process, the 10 subjects concluded that 
indonesian version of Lupus QoL was understandable and 
did not need any fixation. The subjects took about 5 – 10 
minutes to give their answers. Special explanation were given 
to the 15th and 16th statements in Lupus QoL, the sexual 
relationship were considered as intimate relationship in the 
Indonesian version of Lupus QoL. This explanation were 
discussed and agreed by the original author of Lupus QoL. 
The Indonesian version of Lupus QoL then translated back to 
English, and the result was compared to the original version of 
Lupus QoL questionnaire by 2 native speaker. The difference 
then evaluated and discussed. In this study, we found no 
difference between Indonesian and orginal version of Lupus 
QoL questionnaire. 
SF 36 questionnaire
In this study, SF 36 questionaire was given to the subject in 
the first meeting in day 1. In this study the SF 36 was proven 
to have a good internal consistency with cronbach α > 0.7. 
The number of total cronbach α was 0.749 within range of 
0.774 – 0.802 in each domain. The distribution of the data was 
not normal except in Vitality (VT) and Mental Health (MH) 
domain.
Lupus QoL Indonesia
The results from this study, the data were not distributed 
normally by Kolgomorov-Smirnov test with p<0.05. The 
mean of total Lupus QoL score was 7.411 with median 75.74 
(25.74 – 100). The lowest mean score was in fatigue domain 
(68.91) and the highest was planning (79.36). 
External Validity
Four domains that assessed in Lupus QoL and SF 36 were 
equal. The domains are: physical health and vitality; fatigue 
and vitality; pain and bodily pain; emotional health and mental 
health. The correlation test were done to assess any different 
between the four equal domains. Lupus QoL have moderate 
with statistically significant correlation with SF 36 (r : 0.655, 
p<0.05). Each domains (physical health, pain, emotional 
health, and fatique) also showed moderate with statistically 
significant corellation between Lupus QoL and SF 36, as 
presented in Table 2. 
Table 2. Correlation between each domain in Lupus QoL and SF 36
No Lupus QoL Domain SF 36 Domain r P
1 Physical Health Physical Function 0.445 0.000
2 Pain Bodily Pain 0.381 0.005
3 Emotional Health Mental Health 0.636 0.000
4 Fatigue Vitality 0.489 0.000
In this study, we also analyzed the ability of Lupus QoL to 
differentiate the different quality of life related to disease 
activity. The correlational analysis showed that the corelation 
between domain in lupus QoL Indonesia and disease activity 
was weak and not significant (r : -0.06 - -0.16, p : 0.19 – 0.64), 
as presented in table 3. 
Table	3. Correlation between domain in Lupus QoL 
Indonesia and Disease Activity 
No Domain r p
1 Physical health -0.10 0.42
2 Pain -0.10 0.42
3 Planning -0.06 0.64
4 Intimate relationship -0.16 0.19
5 Burden to others -0.10 0.43
6 Emotional health -0.13 0.32
7 Body image -0.13 0.31
8 Fatigue -0.11 0.37
9 Total Lupus QoL -0.13 0.31
This study was also showed that there was no difference 
between active SLE compared to inactive SLE, as seen in 
Table 4.
 
Table 4.  Mean difference of total Lupus QoL Indonesia according 
to disease activity
Domain MEX
SLEDAI<2
(n=49)
MEX 
SLEDAI >2 
(n=16)
Beda 
rerata
P
Physical health 79.34 75.00 4.34 0.38
Pain 76.02 72.40 3.62 0.72
Planning 82.14 70.83 11.31 0.27
Intimate relationship 78.06 77.34 0.72 0.97
Burden to others 70.68 71.35 -0.67 0.34
Emotional Health 70.32 64.58 5.74 0.37
Body Image 77.86 69.38 8.48 0.34
Fatique 68.88 64.06 4.82 0.48
Total Domain 75.36 70.27 5.09 0.47
Construction Validity
Table 5. Correlation between domain and total score of Lupus 
QoL Indonesia
DOMAIN PH P PL IR BO EH BI F
Total 0.81 0.85 0.72 0.46 0.56 0.84 0.67 0.76
PH : Physical health, P: Pain, PL: Planning, IR: Intimate relationship, 
BO: Burden to others, EH: Emotional Health, BI: Body Image, 
F: Fatigue
In this  study, the correlation in the domain of intimate 
relationship, burden to others, body perception has value 
between 0.3 to 0.7 and in domain of physical health, planning, 
emotional health and fatigue showed higher value, above 0.7.( 
0.72 – 0.85 ). Spearman test showed that every question have 
r >0.4. (0.44 – 0.9, CI: 95% dan p<0.05) to the total domain 
score.
Reliability
Lupus QoL questionnaire reliability by analyzing the Intra 
class Correlation Coefficient (ICC) in test and re test. Internal 
consistency was evaluated by measuring the cronbach α. 
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Table 6.  Cronbach α score in Lupus QoL Indonesia
Lupus QoL Cronbach α
Total 0.850
Physical health 0.867
Pain 0.855
Planning 0.868
Intimate relationship 0.892
Burden to others 0.887
Emotional Health 0.858
Body Image 0.882
Fatigue 0.867
In this study Lupus QoL Indonesia showed a good internal 
consistency, with value of cronbach α >0.7
Table 7. Intraclass correlation coefficient in Lupus QoL Indonesia
Test and Re Test Intraclass correlation coefficient
Total 0.948
Physical health/ PH 0.892
Pain/ P 0.802
Planning/ PL 0.748
Intimate relationship/ IR 0.738
Burden to others/ BO 0.839
Emotional Health/ EH 0.944
Body Image/ BI 0.949
Fatigue/ F 0.913
The test and re test reliability of Lupus QoL Indonesia was good 
with ICC > 0.7.
DISCUSSION
This cross sectional study with 65 patients. Female was 
the frequent sex with 63 patients (97%).  This pattern was 
consistent with studies in England 152 patients (95%), United 
States of America 174 patients (94%), China 182 patients 
(88.9%), France 160 patients (88%), Italy 104 patients 
(88.9%) and Turkey 128 patients (97%).24-30 The mean of age 
was 34.97 years (SB 8.551). Median age was 35 years with 
the oldest was 55 years and the youngest was 19 years. Other 
studies showed similar characteristic, such as  study in Italy, 
Turkey, China, France, and Iran showed mean age 40.6 years, 
37.9 years, 33.9 years, 39.6 years, and 36.8 years, respectively.
The level of education in this study was high school in 35 
patients ( 53.8% ). This result had the same level in Iran with 
11.2 years (SB 3.8).28 The disease duration of this study was 
5.98 years (SB 4.616) with p< 0.05. Similar study showed 
that the disease duration was more than 5 years, in Italy 10.63 
years ( SB 7.84 )21, Turkey 5.97 years (SB 4.99)22, Iran 8.2 
years (SB 3.8).23 Mucocutaneus involvement was the frequent 
organ involvement in this study, 61 patients (93.84%). The 
combination of mucocutaneus and musculosceletal was 
the frequen combination in this study 38 patients (58.5%). 
Combination therapy by steroid and azatioprin was the 
frequent combination with 18 patients (12.3%).
 Fourty eight patients (73.8%) had an inactive SLE with 
0 in MEX SLEDAI. The highest disease activity was 9 with 
MEX SLEDAI tertinggi adalah 9 in 1 patients (1.5 %). This 
study showed that most of all SLE patients was in inactive 
state of SLE. This results similar with other studies results in 
Italiy 102 patients (87%), Turkey 75 patients (56.8%), Iran 71 
patients (78.5%) and France 105 patients (62%).
SF 36 questionnaire
In this study we use the SF 36 questionnaire, the results 
showed good internal consistency with cronbach α was 0.799. 
The total cronbach alpha was 0.749. Other studies showed that 
SF 36 Singapore had cronbach α 0.84 – 0.94.18 and China 0.72 
– 0.91.18
Lupus QoL Indonesia questionnaire
The normality study showed that the distibution was not 
normal with p<0.05. The spearman correlation study was used 
to evaluate the correlation. The mean of Lupus QoL total score 
was 74.11(SB 15.04) with Planning domain had a highest score 
with total mean 79.36 (SB 20.28) and the lowest domain was 
fatigue with mean value 67.69 (SB 20.03). The rank of total 
domain score from the lowest was fatigue, emotional health, 
burden to others, pain, body image, intimate relationship, 
physical health, planning. This study was also showed that 
there was a decrease in quality of life in each domain in SLE 
patients. This result was consistent with previous studies. 
Validity
The validity of Indonesian Lupus QoL was done by evaluating 
the external validity and construction validity. 
External validity
In this study the correlation between equal domains in SF 
36 and Indonesian version of Lupus QoL was moderate and 
significant with r : 0.655 and p<0.05 ). Each domain has 
moderate corellation ( r :0.404 – 0.636 ). Similar studies 
showed similar results England (r : 0.71)24, United States of 
America (r: 0.48 – 0.573) 25, France (r: 0.59 – 0.78) 30, Iran 
(0.4) 28, Turkey (0.66 – 0.74).27
 We also analyzed the ability of Lupus QoL Indonesia to 
differentiate the quality of life in two different condition, active 
and inactive SLE. By using the MEX SLEDAI to determine 
the status of the disease activity. However, we found that the 
corelation were weak and not statistically significant ( r : -0.06 
- -0.16, p : 0.19 – 0.64 ). The intimate relationship domain had 
the highest corellation with disease activity and the planning 
domain was the lowest. Using the Mann Whitney test, we 
found that there were no differences in results between the 
active and inactive group.The result was similar to previous 
studies that showed the correlation between quality of life and 
disease activity was inconsistent.12,15,17 In China, there was a 
decrease in quality of Life in each domain, except body image 
domain.29 In Iran, a decrease showed in all domain of Lupus 
QoL, but only in planning, emotional health and body image 
that had a statistically significant.28 In France, only in physical 
health, pain and intimate relationship domain were decrease.30 
In Turkey, a statistically significant decrease showed in all 
of Lupus QoL domain.27 In USA,  a decrease also showed 
across all of Lupus QoL domain, but statistically significant 
Original Article
42 Indonesian Journal of Rheumatology 2016; Vol 8 No.2
only found in physical health, planning, burden to others and 
emotional health.25
 These differences happened not only because of the 
different characteristic of SLE patients and the different 
instrument used to evaluate disease activity, but also because 
of the limitation of the cross sectional study method which 
can not assessed other external factors that could influence the 
QoL, beside the SLE condition itself. In this study, we proved 
that Lupus QoL Indonesia is externally valid.
 
Construction Validity
The construction validity in Lupus QoL Indonesia was proven 
by evaluating the correlation in each total domain score to the 
total Indonesian Lupus QoL score and correlation between 
each questions and the total domain score of Indonesian 
Lupus QoL. We proved that Lupus QoL Indonesia had a good 
construction validity if the correlation coefficient were > 0.4 
in multi trait scaling. The study results showed that physical 
health, planning, mental health and fatigue were correlated 
strongly with total score of Indonesian Lupus QoL and others 
were moderately correlated. All of the results showeed that r 
> 0.4 with p<0.05. In this study, Lupus QoL Indonesia had a 
good construction validity.
Reliability
Internal Consistency
The study showed that the total cronbach α of Lupus QoL 
was 0.850 with the highest score in intimate relationship 
domain and the lowest was in pain domain. The overall value 
of cronbach α was good because its had value > 0.7 (0.86 – 
0.89). This showed that Indonesian Lupus QoL has a good 
internal consistency. 
Test and Re Test Reliability
The TRT reliability was evaluated by using the intra class 
correlation coefficient (ICC). The result showed that the ICC 
were 0.74 – 0.95. Other previous studies showed similar results 
in England (0.72 – 0.93)24, Italy (0.9 – 0.98)26, Turkey (0.88 – 
0.94)27 , China (0.84 – 0.97)29 and France (0.79 – 0.95).30 This 
study proved that TRT reliability of Lupus QoL Indonesia was 
good.
Limitation of the study
We realize that our study has some limitations. Since we used 
consecutive sampling methods, not all SLE population that 
come to our centers have the same opportunities to participate 
in this study. Though, the consecutive sampling methods was 
the best sampling methods for non probability sampling. With 
the amount of the subject study was appropriate to calculate 
the possibility of moderate and significant relationship with 
SF 36. This study only used SLE in ambulatory care setting. 
The external factors that might had impact on quality of life 
were not evaluated such as age, level of education, and other 
disease comorbidities. We also did not exclude or analysis any 
side effect of the therapy.
Conclusion
Lupus QoL questionnaire in Indonesian language is valid 
and reliable to evaluate the quality of life SLE patients in 
Indonesia. Further, a study with more varied population of 
SLE patients is needed.  Besides, we also need to perform a 
study to prove the ability of the lupus QoL quistionnaire to 
detect any change in quality of life of SLE patients that related 
to their disease activity so that it could be applied in clinical 
practice.
Attachment 1
Kuesioner Lupus QoL
Kuesioner berikut dirancang untuk mengetahui bagaimana SLE mempengaruhi 
hidup anda. 
Bacalah setiap pernyataan dan berikan tanda centang pada kotak yang paling 
sesuai dengan apa yang anda rasakan. Jawablah semua pertanyaan dengan 
sejujurnya.
Seberapa seringnya dalam 4 minggu terakhir ini
1. Saya memerlukan bantuan untuk melakukan pekerjaan fisik yang berat 
seperti menggali di taman, mengecat dan atau  mendekorasi, memindah-
kan perabotan karena penyakit lupus yang saya derita.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
2. Saya memerlukan bantuan  untuk melakukan aktivitas fisik sedang seperti 
menyedot debu, menyetrika, berbelanja dan membersihkan kamar mandi 
karena lupus yang saya derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
3. Saya memerlukan bantuan untuk melakukan pekerjaan fisik yang ringan 
seperti memasak, menyiapkan makanan, membuka toples, membersi-
hkan debu, menyisir rambut saya atau membersihkan diri karena lupus 
yang saya derita.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
4. Saya tidak mampu melakukan pekerjaan harian seperti bekerja, mengurus 
anak, mengurus rumah sebaik mungkin karn lupus yang saya derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
5. Saya mengalami kesulitan untuk menaiki tangga karena lupus yang saya 
derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
6. Saya kehilangan sebagian kemandirian saya dan menjadi bergantung 
kepada orang lain karena lupus yang saya derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
7. Saya harus melakukan hal – hal dengan kecepatan yang lebih lambat 
karena lupus yang saya derita karena lupus yang saya derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
8. Saya mengalami gangguan pola tidur karena lupus yang saya derita.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
9. Saya tidak dapat melakukan kegiatan sesuai keinginan saya karena rasa 
sakit yang disebabkan lupus
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
10. Rasa sakit yang saya derita karena penyakit lupus mempengaruhi 
kualitas tidur saya.
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 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
11. Rasa sakit akibat lupus yang saya derita begitu parah sehingga mem-
batasi mobilitas saya.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
12. Saya tidak berencana menghadiri berbagai kegiatan di masa yang akan 
datang karena penyakit lupus.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
13. Saya tidak dapat mengatur hidup saya dengan baik karena ketidakpas-
tian lupus yang saya derita.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
14. Kondisi lupus yang saya derita bervariasi dari hari ke hari sehingga mem-
buat saya sulit untuk berkomitmen dengan acara – acara sosial saya
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
15. Saya kurang tertarik pada hubungan seksual karena sakit yang saya 
rasakan akibat lupus.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
16. Saya tidak tertarik pada hubungan seks karena penyakit lupus saya.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
17. Saya khawatir penyakit lupus yang saya derita menyebabkan stress bagi 
mereka yang dekat dengan saya
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
18. Saya merasa prihatin jika saya menyebabkan kekhawatiran bagi mereka 
yang dekat dengan saya karena penyakit lupus yang saya derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
19. Saya merasa menjadi beban bagi keluarga dan atau teman saya karena 
lupus yang saya derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
Dalam 4 minggu terakhir saya merasa lupus membuat saya
20. Marah
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
21. Sangat muak dengan keadaan saya sehingga tidak ada yang bisa meny-
enangkan saya
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
22. Sedih
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
23. Cemas
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
24. Khawatir
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
25. Kurang percaya diri
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
Seberapa sering dalam  4 minggu terakhir
26. Penampilan fisik saya akibat lupus mengganggu saya menikmati kehidu-
pan.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
27. Saya merasa penampilan saya karena lupus (dengan rash, kenaikan 
berat badan/ penurunan berat badan) membuat saya menghindari 
pertemuan sosial
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
28. Ruam  kemerahan pada kulit yang disebabkan oleh lupus membuat saya 
merasa kurang menarik
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
29. Rambut rontok yang disebabkan oleh lupus membuat saya merasa 
kurang menarik
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
30. Kenaikan berat badan yang saya alami akibat pengobatan lupus mem-
buat saya merasa kurang menarik.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
31. Saya tidak dapat berkonsentrasi untuk waktu yang lama karena lupus 
yang saya derita.
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
32. Saya merasa lelah dan lesu karena lupus yang saya derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
33. Saya harus tidur lebih awal  karena lupus yang saya derita,
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
34. Saya merasa kelelahan pada pagi hari akibat lupus yang saya derita
 Setiap
saat
 seringkali  cukup
banyak
 Kadang- 
kadang
 Tidak
pernah
Pastikan anda telah menjawab setiap pertanyaan.
Keterangan tambahan : Hubungan seksual dan hubungan seks pada 
pernyataan 15 dan 16 diartikan sebagai hubungan intim
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